Pages that link to "Q46130784"

The following pages link to Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms (Q46130784):

Displaying 22 items.

• Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials (Q21260328) (← links)
• Iloperidone, asenapine and lurasidone: a primer on their current status (Q34641024) (← links)
• Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat (Q35179053) (← links)
• An update of safety of clinically used atypical antipsychotics (Q36062184) (← links)
• Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration (Q37012177) (← links)
• Asenapine (Q37581589) (← links)
• Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder (Q37737289) (← links)
• Treatment Strategies for Dosing the Second Generation Antipsychotics (Q37852818) (← links)
• Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. (Q37954123) (← links)
• Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice (Q38077281) (← links)
• Management of schizophrenia: clinical experience with asenapine. (Q38093729) (← links)
• Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series (Q38236045) (← links)
• Effects of asenapine on prefrontal N‐methyl‐D‐aspartate receptor‐mediated transmission: Involvement of dopamine D1 receptors (Q42906958) (← links)
• Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism (Q45145553) (← links)
• Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism (Q46859633) (← links)
• Asenapine reduces anxiety-related behaviours in rat conditioned fear stress model (Q47376793) (← links)
• Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial (Q47661666) (← links)
• Asenapine modulates mood-related behaviors and 5-HT1A/7 receptors-mediated neurotransmission. (Q47741137) (← links)
• Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. (Q48466348) (← links)
• Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow (Q48643283) (← links)
• An enhancement of the firing activity of dopamine neurons as a common denominator of antidepressant treatments? (Q48908106) (← links)
• Dopamine D4 receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia (Q50590446) (← links)